FOLD
Featured PickAmicus Therapeutics, Inc.
Real picks. Real tracking. We bet on one stock daily and show you exactly how it plays out.
AI Confidence Score
72
Entry Price
$14.47
Current Price
$24.29
Total Return
+0.00%
vs SPY
+0.00%
As of Close 2026-04-07
Executive Summary
FOLD is experiencing a massive 8.0x relative volume spike as shareholders officially approve its acquisition by BioMarin Pharmaceutical. This heavy institutional accumulation near the $14.50 buyout price signals absolute confidence in the deal's imminent closure. In today's RISK_ON regime where compressing volatility and geopolitical relief are driving aggressive positioning, FOLD serves as a high-probability arbitrage anchor.
Technical Context
Setup
The stock boasts a high confluence score of 15.0 and is positioned just 0.7% below its 52-week high at $14.46, supported by an unprecedented 8.0x volume spike.
Invalidation (Stop)
A breakdown below the $14.36 support level would indicate unexpected deal friction or regulatory hurdles, invalidating the setup.
Runner-ups
KNX— Solid analyst upgrade and technicals, but lacks the volume confirmation (0.7x) needed for a high-conviction breakout
Recent Performance History
44 Total Picks • 55% Win Rate (7d)
| Date | Ticker | Entry | Last | Gain/Loss | 7d | 30d | 60d |
|---|---|---|---|---|---|---|---|
| 2026-04-06 | ROL | $54.13 | $53.70 | -0.79% | N/A | N/A | N/A |
| 2026-04-02 | DAR | $64.65 | $63.89 | -1.18% | N/A | N/A | N/A |
| 2026-04-01 | FOLD | $14.44 | $14.47 | +0.21% | N/A | N/A | N/A |
| 2026-03-31 | TKO | $201.65 | $197.02 | -2.30% | -2.30% | N/A | N/A |
| 2026-03-30 | TKO | $195.41 | $197.02 | +0.82% | +0.82% | N/A | N/A |
| 2026-03-27 | PRA | $24.58 | $24.29 | -1.18% | -1.55% | N/A | N/A |
| 2026-03-26 | DAR | $58.98 | $63.89 | +8.32% | +9.61% | N/A | N/A |
| 2026-03-25 | ST | $36.40 | $34.99 | -3.87% | -3.35% | N/A | N/A |
| 2026-03-24 | DBRG | $15.40 | $15.47 | +0.45% | +0.13% | N/A | N/A |
| 2026-03-23 | DBRG | $15.38 | $15.47 | +0.59% | +0.13% | N/A | N/A |
Schema v1.0 | Pipeline v1.2.0